At a Glance - Illumina, Inc. · At a Glance We serve research and clinical customers in a broad...
1
$100 million † $1,000 †† At a Glance We serve research and clinical customers in a broad range of markets, including: Who We Serve As the global leader in sequencing and array-based technologies, we aim to transform human health. From cancer research to prenatal screening to food safety, the applications of our technology are as universal as life itself. Who We Are Quick facts Jay Flatley CEO $1.86 billion (2014) Annual revenue 1998 Year founded 4,300+ Number of employees San Diego, California, USA Headquarters Oncology Forensics Complex diseases Reproductive health Microbiology Agriculture We enable the adoption of genomic solutions in settings such as: Universities and academic research centers Genome centers Hospitals Government agencies Pharmaceutical companies Biotechnology companies Consumer genetics companies San Diego, CA United States (headquarters) San Francisco Bay Area, CA United States Madison, WI United States São Paulo Brazil Cambridge United Kingdom Eindhoven Netherlands Shanghai China Singapore Tokyo Japan Melbourne Australia Beijing China Illumina has developed the world’s most comprehensive genomics portfolio of integrated systems, consumables, and analysis tools. With each technological breakthrough, we help scientists better understand genetic variation at all levels of complexity. Sequencing Systems Making Breakthroughs Possible HiSeq X ™ Series Maximum throughput and low cost population and production-scale human whole-genome sequencing. Series includes the HiSeq X Ten and the new HiSeq X Five Systems. HiSeq ® Series Maximum throughput and lowest cost for production-scale genomics. Series includes the new HiSeq 3000 and HiSeq 4000 Systems. NextSeq ® Series Desktop speed and simplicity for everyday genomics. Series includes the NextSeq 500 and thenew NextSeq 550 with cytogenomic array scanning. Array Scanners 2001 2014 Cost of sequencing, per human whole genome In only 13 years, the cost of DNA sequencing has dropped 1,000x from $100 million per human genome to $1,000 today. Discoveries that were unimaginable a few years ago are now becoming routine. A Recognized Leader World’s Most Innovative Companies List Forbes 2014 (#36) Forbes 2015 (#35) 50 Smartest Companies MIT Technology Review 2014 (#1), 2015 (#3) 12 Most Disruptive Names in Business (Jay Flatley, CEO) Forbes 2013 10 Breakthrough Technologies 2013 MIT Technology Review 2013 Top 50 Disruptive Companies MIT Technology Review 2010, 2013 Fastest-Growing Tech Companies Forbes 2007, 2009, 2010 To learn how Illumina is unlocking the power of the genome, visit www.illumina.com and follow us @illumina. Sources: † Wetterstrand KA. DNA Sequencing Costs: Data from the NHGRI Genome Sequencing Program (GSP). Available at: www.genome.gov/sequencingcosts †† Illumina, Inc. HiSeq XTM Ten: $1,000 Genome and Extreme Throughput for Population-scale Sequencing. Available at: http://systems.illumina.com/content/dam/illumina-marketing/documents/products/datasheets/datasheet-hiseq-x-ten.pdf HiScan ® System iScan ® System Genotyping, CNV analysis, DNA methylation, and gene expression profiling. Where We Operate MiSeq ® Series Speed and simplicity for targeted and small-genome sequencing. Series includes the MiSeq, MiSeqDx ® and MiSeq FGx ™ Systems.* *MiSeqDx ® is a 510(k) cleared, CE-marked instrument. MiSeq FGx™ is for forensic genomics applications.
Transcript of At a Glance - Illumina, Inc. · At a Glance We serve research and clinical customers in a broad...
$100 million†
$1,000††
At a Glance
We serve research and clinical customers in a broad rangeof markets, including:
Who We ServeAs the global leader in sequencing and array-based technologies, we aim to transform human health. From cancer research to prenatal screening to food safety, the applications of our technology are as universal as life itself.
Who We Are
Quick facts
Jay FlatleyCEO
$1.86 billion (2014)Annual revenue
1998Year founded
4,300+Number of employees
San Diego, California, USAHeadquarters
Oncology Forensics Complex diseases
Reproductive health
MicrobiologyAgriculture
We enable the adoption of genomic solutions in settings such as:
Universities and academic
research centersGenome centers Hospitals
Government agencies
Pharmaceutical companies
Biotechnology companies
Consumer genetics
companies
San Diego, CAUnited States(headquarters)
San FranciscoBay Area, CAUnited States
Madison, WIUnited States
São PauloBrazil
CambridgeUnited Kingdom
EindhovenNetherlands Shanghai
ChinaSingapore
TokyoJapan
MelbourneAustralia
BeijingChina
Illumina has developed the world’s most comprehensive genomics portfolio of integrated systems, consumables, and analysis tools. With each technological breakthrough, we help scientists better understand genetic variation at all levels of complexity.
Sequencing Systems
Making Breakthroughs Possible
HiSeq X™ SeriesMaximum throughput and low cost population and production-scale human whole-genome sequencing.Series includes the HiSeq X Ten and the new HiSeq X Five Systems.
HiSeq® SeriesMaximum throughput and lowest costfor production-scale genomics. Seriesincludes the new HiSeq 3000 and HiSeq 4000 Systems.
NextSeq® SeriesDesktop speed and simplicity for everyday genomics. Series includes the NextSeq 500 and thenew NextSeq 550 with cytogenomic array scanning.
Array Scanners
2001
2014
Cost of sequencing, per human whole genome
In only 13 years, the cost of DNA sequencing has dropped 1,000x from $100 million per human genome to $1,000 today. Discoveries that were unimaginable a few years ago are now becoming routine.
A Recognized Leader
World’s Most Innovative Companies ListForbes 2014 (#36)Forbes 2015 (#35)
50 Smartest CompaniesMIT Technology Review 2014 (#1), 2015 (#3)
12 Most Disruptive Names in Business (Jay Flatley, CEO) Forbes 2013
10 Breakthrough Technologies 2013 MIT Technology Review 2013
Top 50 Disruptive Companies MIT Technology Review 2010, 2013
Fastest-Growing Tech Companies Forbes 2007, 2009, 2010
To learn how Illumina is unlocking the power of the genome, visit www.illumina.com and follow us @illumina.Sources: † Wetterstrand KA. DNA Sequencing Costs: Data from the NHGRI Genome Sequencing Program (GSP). Available at: www.genome.gov/sequencingcosts†† Illumina, Inc. HiSeq XTM Ten: $1,000 Genome and Extreme Throughput for Population-scale Sequencing. Available at: http://systems.illumina.com/content/dam/illumina-marketing/documents/products/datasheets/datasheet-hiseq-x-ten.pdf
HiScan® System iScan® System
Genotyping, CNV analysis, DNA methylation, and gene expression profiling.
Where We Operate
MiSeq® SeriesSpeed and simplicity for targeted and small-genome sequencing. Series includes the MiSeq, MiSeqDx® andMiSeq FGx™ Systems.**MiSeqDx® is a 510(k) cleared, CE-marked instrument. MiSeq FGx™is for forensic genomics applications.
